The 'Henry Ford of Heart Surgery' and His Promise
Dr. Devi Shetty, founder of Narayana Health, became a national icon with a powerful, disruptive idea: applying industrial-scale efficiency to healthcare. Dubbed the 'Henry Ford of heart surgery', his model aimed to drastically cut costs by performing
a high volume of procedures. This 'Walmart approach' involved running operating theatres for extended hours, paying doctors fixed salaries instead of per-surgery fees, and using economies of scale to negotiate lower prices for medical supplies. The most cited forecast, emerging over a decade ago, suggested that this model could bring the cost of a heart bypass surgery down to as low as $800 (around ₹65,000 today). This promise wasn't just about cheap surgeries; it was about fundamentally decoupling quality healthcare from wealth, a mission that made Narayana Health a case study at institutions like Harvard Business School.
The Current Price Reality: A Widening Gap
Today, while Narayana Health remains significantly more affordable than its Western counterparts, the $800 forecast is largely a relic of a different economic era. Recent data from 2026 shows that the indicative cost for a Coronary Artery Bypass Grafting (CABG) surgery at a Narayana Health facility can start from ₹1,82,000 and go up to ₹6,50,000, depending on the complexity and choice of room. An angioplasty can range between ₹3,80,000 to ₹4,10,000. While these prices are still a fraction of the cost in the US or UK, they are considerably higher than the sub-₹1 lakh figures that once defined the hospital's ambitious goals. This discrepancy is the core of the debate: if the model is built for efficiency, what factors are driving prices up?
The Unavoidable Force of Medical Inflation
One of the primary culprits is relentless medical inflation in India, which consistently outpaces general inflation. In 2026, reports peg medical inflation between 11.5% and 14%, among the highest rates in Asia. This is not just a general rise in prices. It’s driven by specific factors like the cost of advanced medical technology, imported equipment and consumables, and specialty medications. Hospitals, including Narayana Health, must invest in modern equipment to maintain high standards of care, and these costs are invariably passed on to the patient. A procedure's cost isn't just the surgeon's time; it includes everything from high-tech scanners to sterilised consumables, all subject to steep price hikes.
Systemic Hurdles Beyond Hospital Walls
Dr. Shetty's model of internal efficiency runs into external systemic challenges. The cost of real estate for building new hospitals, regulatory compliance, and a shortage of skilled healthcare professionals all contribute to rising operational expenses. Furthermore, while Narayana Health has perfected 'task shifting'—where nurses and technicians handle tasks to free up surgeons—scaling this requires a continuous supply of trained staff, a challenge across the Indian healthcare sector. The overall healthcare infrastructure in the country remains underfunded, putting more pressure on private players to fill the gap, but at a cost. Even with the world's most efficient factory, the price of raw materials and logistics dictates the final price of the product.
Where the Vision Succeeded—And What’s Next
Despite the gap in price points, it's a mistake to call the vision a failure. Dr. Shetty's model has profoundly influenced Indian healthcare, proving that high-volume, high-quality care is possible. Narayana Health performs about 12% of all heart surgeries in India, and its principles have been integrated into public policy, such as the Yeshasvini insurance scheme he helped pioneer. The focus on affordability has also intensified competition among private hospitals, helping to keep a check on prices across the board. Looking ahead, Dr. Shetty himself now points to technology, like AI and robotics, as the next frontier for cost reduction, forecasting potential cost cuts of 40-50% in the next five to seven years. The original forecast may be unmet, but the drive to innovate on cost continues.
















